Assessment of Abnormal Serum Analytes in Low-Risk Patients for the Prevention of Adverse Pregnancy Outcomes

      To determine the occurrence rate of adverse pregnancy outcomes in patients with abnormal serum analytes who screen low-risk for trisomy 21 and 18 on first trimester screening for fetal aneuploidy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect